Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532421) titled 'Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life' on April 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Peking University Third Hospital
Condition:
Antibiotic
Allergic Diseases
Infants
Probiotic
Intervention:
Dietary Supplement: Probiotic mixture
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 17, 2026
Target Sample Size: 400
Countries of R...